Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT03121690 |
Other study ID # |
17200051 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
Phase 4
|
First received |
|
Last updated |
|
Start date |
December 1, 2017 |
Est. completion date |
December 1, 2020 |
Study information
Verified date |
November 2020 |
Source |
Assiut University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Cross sectional randomized clinical trial study will be done at Respiratory intensive care
unit and Chest department at Assiut University Hospitals on All patients who developed
hospital acquired pneumonia including ventilator associated pneumonia through two years
duration to assess the prognostic value of different severity scores including (PSI, CURB65,
SMART COP, IDSA/ATS and SOAR) in patients with HAP, assess platelet count as a marker for
severity, evaluate efficacy and safety of adjuvant systemic steroids in patients with severe
conditions and measurement of cortisol level to assess steroid response before
administration.
Description:
The following parameters will be recorded:
- Demographic data: including age, sex, smoking history.
- Clinical data: Glasgow coma scales, Co-morbidities are determined by reviewing the
patients' clinical histories, chest examination.
- Vital signs: including body temperature, respiratory rate, heart rate, and arterial
blood pressure.
- Oxygenation data: including arterial blood gases in fixed days (at the start, 3rd day
and 7th day of steroid administration), ratio of partial oxygen tension in arterial
blood to fraction of inspired oxygen (PaO2/FiO2 ratio).
- Laboratory data include complete blood picture focusing on leukocytic count and
platelets, kidney and liver function tests, serum electrolytes, Erythrocyte
sedimentation rate, C reactive protein, sputum culture and cortisol level before steroid
administration.
- Radiology data include chest X-ray and chest ultrasonography at the day of diagnosis and
at 7th day of steroid administration. Chest CT will be done if possible.
Procedures: Systemic steroids will be administered early with a dosages equivalent to
prednisone 40 mg/day for 7 days which is considered as a "stress dose" of systemic
corticosteroids for pneumonia. The patients will also receive the appropriate initial
intravenous antibiotic medication and the standard care as recommended in RICU policy.
Cortisol level will be measured before steroid administration.